rosiglitazone has been researched along with Hepatitis B in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, L; Gao, F; Huang, S; Zhang, L; Zhao, S; Zhen, Y; Zhou, X | 1 |
| Chen, S; Chen, Y; Fu, L; Zhang, L | 1 |
| Chen, R; Duan, F; Huang, S; Lin, T; Lv, J; Ma, H; Nie, L; Ren, L; Shan, W; Zhang, J | 1 |
| Beuers, U; Donkers, JM; IJzerman, AP; Kwakkenbos, MJ; Oude Elferink, RPJ; Urban, S; van de Graaf, SFJ; van Westen, GJP; Zehnder, B | 1 |
| Dansako, H; Gu, W; Kato, N; Nishitsuji, H; Satoh, S; Shimotohno, K; Ueda, Y | 1 |
| Fukushima, K; Inoue, J; Kakazu, E; Kimura, O; Kondo, Y; Obara, N; Shimosegawa, T; Ueno, Y; Wakui, Y | 1 |
| Chow, WH; Davies, C; Jiang, J; Li, GW; Pan, CY; Shi, HL; Sun, XC; Tian, H; Yang, WY; Zhu, XX | 1 |
1 review(s) available for rosiglitazone and Hepatitis B
| Article | Year |
|---|---|
Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.
Topics: Carcinoma, Hepatocellular; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Interferons; Liver Neoplasms; Nucleotides; Organic Anion Transporters, Sodium-Dependent; Symporters; Virus Internalization | 2022 |
1 trial(s) available for rosiglitazone and Hepatitis B
| Article | Year |
|---|---|
Addition of rosiglitazone to existing sulfonylurea treatment in chinese patients with type 2 diabetes and exposure to hepatitis B or C.
Topics: Adult; Asian People; Blood Glucose; China; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Environmental Exposure; Female; Gliclazide; Glyburide; Glycated Hemoglobin; Hepatitis B; Hepatitis C; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Rosiglitazone; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones | 2003 |
5 other study(ies) available for rosiglitazone and Hepatitis B
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of benzamide derivatives as novel NTCP inhibitors that induce apoptosis in HepG2 cells.
Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Benzamides; Drug Design; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; Molecular Docking Simulation; Organic Anion Transporters, Sodium-Dependent; Symporters; Virus Internalization | 2019 |
Photoacoustic molecular imaging-escorted adipose photodynamic-browning synergy for fighting obesity with virus-like complexes.
Topics: Adipose Tissue, White; Animals; Hepatitis B; Humans; Indoles; Mice; Molecular Imaging; Obesity; Organometallic Compounds; Photoacoustic Techniques; Rosiglitazone; Viral Core Proteins | 2021 |
Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP.
Topics: Animals; Antiviral Agents; Dogs; Hepatitis B; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; Humans; Indoles; Lipopeptides; Madin Darby Canine Kidney Cells; Organic Anion Transporters, Sodium-Dependent; Phenylcarbamates; Rosiglitazone; Sulfasalazine; Sulfonamides; Symporters; Tosyl Compounds; Triiodothyronine; Trypan Blue; Virus Internalization | 2017 |
A new hepatoma cell line exhibiting high susceptibility to hepatitis B virus infection.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cyclosporine; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Host-Pathogen Interactions; Humans; Liver Neoplasms; Organic Anion Transporters, Sodium-Dependent; Rosiglitazone; Symporters; Virus Internalization | 2019 |
Inhibitory effect on hepatitis B virus in vitro by a peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Ligands; PPAR gamma; Rosiglitazone; Thiazolidinediones; Virus Replication | 2010 |